Clinical Report: Cognitive Impairment in Coronary Heart Disease Patients
Overview
Cognitive impairment is prevalent in 36.6% of patients with coronary heart disease (CHD). Significant risk factors include age, history of stroke, smoking, diabetes, depression, and anxiety.
Background
Cognitive impairment is a critical concern in patients with coronary heart disease (CHD), as it can significantly affect their quality of life and self-management capabilities. The increasing prevalence of CHD, projected to rise to 18% by 2030, underscores the need for effective identification and intervention strategies for cognitive decline. Understanding the prevalence and associated risk factors of cognitive impairment in this population is essential for improving patient outcomes.
Data Highlights
Measure
Value
Prevalence of Cognitive Impairment
36.6% (95% CI 27.6%–45.7%)
Key Findings
The prevalence of cognitive impairment in CHD patients is 36.6%.
Age is a significant risk factor with an odds ratio (OR) of 1.10.
A history of stroke increases the risk with an OR of 1.99.
Smoking is associated with a higher risk (OR: 3.05).
Diabetes and negative emotions such as depression (OR: 1.67) and anxiety (OR: 2.03) are also significant risk factors.
No significant correlation was found between cognitive impairment and education level, hypertension, systolic blood pressure, or HDL-C.
Clinical Implications
Healthcare professionals should prioritize the identification of high-risk groups for cognitive impairment among CHD patients, particularly the elderly, smokers, and those with a history of stroke or diabetes. Implementing dynamic assessments and targeted interventions can help mitigate the risk of cognitive decline and improve patient management.
Conclusion
Cognitive impairment is a significant concern in patients with coronary heart disease, necessitating early identification and intervention strategies. Addressing the identified risk factors can enhance patient care and outcomes.
